nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CYP1B1—Omeprazole—Barrett's esophagus	0.213	0.391	CbGbCtD
Dasatinib—ABCG2—Omeprazole—Barrett's esophagus	0.101	0.186	CbGbCtD
Dasatinib—CYP1A1—Omeprazole—Barrett's esophagus	0.0936	0.172	CbGbCtD
Dasatinib—CYP1A2—Omeprazole—Barrett's esophagus	0.0418	0.0766	CbGbCtD
Dasatinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0372	0.0681	CbGbCtD
Dasatinib—ABCB1—Omeprazole—Barrett's esophagus	0.0366	0.067	CbGbCtD
Dasatinib—CYP3A4—Omeprazole—Barrett's esophagus	0.0219	0.0401	CbGbCtD
Dasatinib—Oral disorder—Esomeprazole—Barrett's esophagus	0.00563	0.0266	CcSEcCtD
Dasatinib—Oral disorder—Omeprazole—Barrett's esophagus	0.00563	0.0266	CcSEcCtD
Dasatinib—ERBB3—exocrine gland—Barrett's esophagus	0.00488	0.0483	CbGeAlD
Dasatinib—BMX—epithelium—Barrett's esophagus	0.00398	0.0394	CbGeAlD
Dasatinib—STAT5B—epithelium—Barrett's esophagus	0.00353	0.0349	CbGeAlD
Dasatinib—KIT—exocrine gland—Barrett's esophagus	0.00298	0.0296	CbGeAlD
Dasatinib—EPHB2—digestive system—Barrett's esophagus	0.00296	0.0293	CbGeAlD
Dasatinib—SRMS—digestive system—Barrett's esophagus	0.0029	0.0287	CbGeAlD
Dasatinib—PTK6—digestive system—Barrett's esophagus	0.00284	0.0281	CbGeAlD
Dasatinib—BMPR1B—epithelium—Barrett's esophagus	0.00283	0.028	CbGeAlD
Dasatinib—STAT5B—digestive system—Barrett's esophagus	0.00268	0.0266	CbGeAlD
Dasatinib—Tongue oedema—Omeprazole—Barrett's esophagus	0.00254	0.012	CcSEcCtD
Dasatinib—Tongue oedema—Esomeprazole—Barrett's esophagus	0.00254	0.012	CcSEcCtD
Dasatinib—Generalised oedema—Omeprazole—Barrett's esophagus	0.00239	0.0113	CcSEcCtD
Dasatinib—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.00239	0.0113	CcSEcCtD
Dasatinib—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.00239	0.0113	CcSEcCtD
Dasatinib—Generalised oedema—Esomeprazole—Barrett's esophagus	0.00239	0.0113	CcSEcCtD
Dasatinib—Polyp—Omeprazole—Barrett's esophagus	0.00234	0.0111	CcSEcCtD
Dasatinib—Polyp—Esomeprazole—Barrett's esophagus	0.00234	0.0111	CcSEcCtD
Dasatinib—Optic neuritis—Esomeprazole—Barrett's esophagus	0.00231	0.0109	CcSEcCtD
Dasatinib—Optic neuritis—Omeprazole—Barrett's esophagus	0.00231	0.0109	CcSEcCtD
Dasatinib—CSK—smooth muscle tissue—Barrett's esophagus	0.0023	0.0228	CbGeAlD
Dasatinib—ZAK—digestive system—Barrett's esophagus	0.00224	0.0222	CbGeAlD
Dasatinib—RIPK2—epithelium—Barrett's esophagus	0.00222	0.022	CbGeAlD
Dasatinib—EPHA5—digestive system—Barrett's esophagus	0.00219	0.0217	CbGeAlD
Dasatinib—Cyst—Omeprazole—Barrett's esophagus	0.00213	0.0101	CcSEcCtD
Dasatinib—Cyst—Esomeprazole—Barrett's esophagus	0.00213	0.0101	CcSEcCtD
Dasatinib—ERBB3—epithelium—Barrett's esophagus	0.00212	0.021	CbGeAlD
Dasatinib—MAPK14—epithelium—Barrett's esophagus	0.00198	0.0196	CbGeAlD
Dasatinib—Tongue disorder—Esomeprazole—Barrett's esophagus	0.00196	0.00924	CcSEcCtD
Dasatinib—Tongue disorder—Omeprazole—Barrett's esophagus	0.00196	0.00924	CcSEcCtD
Dasatinib—EPHB3—digestive system—Barrett's esophagus	0.00195	0.0193	CbGeAlD
Dasatinib—MAPK14—smooth muscle tissue—Barrett's esophagus	0.0019	0.0189	CbGeAlD
Dasatinib—EPHB4—epithelium—Barrett's esophagus	0.00187	0.0186	CbGeAlD
Dasatinib—JAK2—epithelium—Barrett's esophagus	0.00186	0.0184	CbGeAlD
Dasatinib—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00186	0.00878	CcSEcCtD
Dasatinib—Rash erythematous—Omeprazole—Barrett's esophagus	0.00186	0.00878	CcSEcCtD
Dasatinib—EPHA2—epithelium—Barrett's esophagus	0.00184	0.0182	CbGeAlD
Dasatinib—CSK—digestive system—Barrett's esophagus	0.00182	0.018	CbGeAlD
Dasatinib—EPHB4—smooth muscle tissue—Barrett's esophagus	0.0018	0.0179	CbGeAlD
Dasatinib—HCK—digestive system—Barrett's esophagus	0.00179	0.0178	CbGeAlD
Dasatinib—JAK2—smooth muscle tissue—Barrett's esophagus	0.00179	0.0177	CbGeAlD
Dasatinib—FYN—smooth muscle tissue—Barrett's esophagus	0.00177	0.0175	CbGeAlD
Dasatinib—Petechiae—Omeprazole—Barrett's esophagus	0.00173	0.00817	CcSEcCtD
Dasatinib—Petechiae—Esomeprazole—Barrett's esophagus	0.00173	0.00817	CcSEcCtD
Dasatinib—MAP4K5—smooth muscle tissue—Barrett's esophagus	0.00173	0.0171	CbGeAlD
Dasatinib—RIPK2—digestive system—Barrett's esophagus	0.00169	0.0167	CbGeAlD
Dasatinib—Proteinuria—Esomeprazole—Barrett's esophagus	0.00162	0.00765	CcSEcCtD
Dasatinib—Proteinuria—Omeprazole—Barrett's esophagus	0.00162	0.00765	CcSEcCtD
Dasatinib—ERBB3—digestive system—Barrett's esophagus	0.00161	0.016	CbGeAlD
Dasatinib—Protein urine present—Esomeprazole—Barrett's esophagus	0.0016	0.00755	CcSEcCtD
Dasatinib—Protein urine present—Omeprazole—Barrett's esophagus	0.0016	0.00755	CcSEcCtD
Dasatinib—YES1—smooth muscle tissue—Barrett's esophagus	0.00159	0.0158	CbGeAlD
Dasatinib—SRC—epithelium—Barrett's esophagus	0.00159	0.0158	CbGeAlD
Dasatinib—PDGFRA—smooth muscle tissue—Barrett's esophagus	0.00156	0.0155	CbGeAlD
Dasatinib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00155	0.00734	CcSEcCtD
Dasatinib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00155	0.00734	CcSEcCtD
Dasatinib—SRC—smooth muscle tissue—Barrett's esophagus	0.00153	0.0152	CbGeAlD
Dasatinib—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00153	0.00725	CcSEcCtD
Dasatinib—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00153	0.00725	CcSEcCtD
Dasatinib—MAPK14—digestive system—Barrett's esophagus	0.0015	0.0149	CbGeAlD
Dasatinib—FGR—digestive system—Barrett's esophagus	0.0015	0.0148	CbGeAlD
Dasatinib—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00149	0.00706	CcSEcCtD
Dasatinib—Creatinine increased—Omeprazole—Barrett's esophagus	0.00149	0.00706	CcSEcCtD
Dasatinib—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00145	0.00685	CcSEcCtD
Dasatinib—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00145	0.00685	CcSEcCtD
Dasatinib—EPHB4—digestive system—Barrett's esophagus	0.00142	0.0141	CbGeAlD
Dasatinib—JAK2—digestive system—Barrett's esophagus	0.00141	0.014	CbGeAlD
Dasatinib—EPHA2—digestive system—Barrett's esophagus	0.0014	0.0138	CbGeAlD
Dasatinib—FYN—digestive system—Barrett's esophagus	0.00139	0.0138	CbGeAlD
Dasatinib—CSF1R—smooth muscle tissue—Barrett's esophagus	0.00138	0.0136	CbGeAlD
Dasatinib—Fluid retention—Omeprazole—Barrett's esophagus	0.00135	0.00638	CcSEcCtD
Dasatinib—Fluid retention—Esomeprazole—Barrett's esophagus	0.00135	0.00638	CcSEcCtD
Dasatinib—Dry eye—Esomeprazole—Barrett's esophagus	0.00131	0.00621	CcSEcCtD
Dasatinib—Dry eye—Omeprazole—Barrett's esophagus	0.00131	0.00621	CcSEcCtD
Dasatinib—Oesophagitis—Omeprazole—Barrett's esophagus	0.0013	0.00614	CcSEcCtD
Dasatinib—Oesophagitis—Esomeprazole—Barrett's esophagus	0.0013	0.00614	CcSEcCtD
Dasatinib—KIT—epithelium—Barrett's esophagus	0.0013	0.0129	CbGeAlD
Dasatinib—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00129	0.00611	CcSEcCtD
Dasatinib—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00129	0.00611	CcSEcCtD
Dasatinib—Neoplasm—Omeprazole—Barrett's esophagus	0.00129	0.00608	CcSEcCtD
Dasatinib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00129	0.00608	CcSEcCtD
Dasatinib—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00127	0.00602	CcSEcCtD
Dasatinib—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00127	0.00602	CcSEcCtD
Dasatinib—PDGFRB—epithelium—Barrett's esophagus	0.00127	0.0126	CbGeAlD
Dasatinib—YES1—digestive system—Barrett's esophagus	0.00126	0.0125	CbGeAlD
Dasatinib—KIT—smooth muscle tissue—Barrett's esophagus	0.00125	0.0124	CbGeAlD
Dasatinib—PDGFRA—digestive system—Barrett's esophagus	0.00124	0.0122	CbGeAlD
Dasatinib—PDGFRB—smooth muscle tissue—Barrett's esophagus	0.00122	0.0121	CbGeAlD
Dasatinib—SRC—digestive system—Barrett's esophagus	0.00121	0.012	CbGeAlD
Dasatinib—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00118	0.00556	CcSEcCtD
Dasatinib—Photosensitivity—Omeprazole—Barrett's esophagus	0.00118	0.00556	CcSEcCtD
Dasatinib—Visual disturbance—Omeprazole—Barrett's esophagus	0.00109	0.00515	CcSEcCtD
Dasatinib—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00109	0.00515	CcSEcCtD
Dasatinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00109	0.0108	CbGeAlD
Dasatinib—CSF1R—digestive system—Barrett's esophagus	0.00109	0.0108	CbGeAlD
Dasatinib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00103	0.00488	CcSEcCtD
Dasatinib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00103	0.00488	CcSEcCtD
Dasatinib—Face oedema—Esomeprazole—Barrett's esophagus	0.000997	0.00471	CcSEcCtD
Dasatinib—Face oedema—Omeprazole—Barrett's esophagus	0.000997	0.00471	CcSEcCtD
Dasatinib—KIT—digestive system—Barrett's esophagus	0.000987	0.00978	CbGeAlD
Dasatinib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000967	0.00457	CcSEcCtD
Dasatinib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000967	0.00457	CcSEcCtD
Dasatinib—PDGFRB—digestive system—Barrett's esophagus	0.000964	0.00955	CbGeAlD
Dasatinib—Dry skin—Esomeprazole—Barrett's esophagus	0.000946	0.00447	CcSEcCtD
Dasatinib—Dry skin—Omeprazole—Barrett's esophagus	0.000946	0.00447	CcSEcCtD
Dasatinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00094	0.00444	CcSEcCtD
Dasatinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00094	0.00444	CcSEcCtD
Dasatinib—Breast disorder—Omeprazole—Barrett's esophagus	0.000933	0.00441	CcSEcCtD
Dasatinib—Breast disorder—Esomeprazole—Barrett's esophagus	0.000933	0.00441	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00093	0.00439	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00093	0.00439	CcSEcCtD
Dasatinib—CYP1B1—smooth muscle tissue—Barrett's esophagus	0.000922	0.00913	CbGeAlD
Dasatinib—Gastritis—Esomeprazole—Barrett's esophagus	0.000914	0.00432	CcSEcCtD
Dasatinib—Gastritis—Omeprazole—Barrett's esophagus	0.000914	0.00432	CcSEcCtD
Dasatinib—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000911	0.0043	CcSEcCtD
Dasatinib—Muscular weakness—Omeprazole—Barrett's esophagus	0.000911	0.0043	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000911	0.0043	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000911	0.0043	CcSEcCtD
Dasatinib—Abdominal distension—Omeprazole—Barrett's esophagus	0.000898	0.00425	CcSEcCtD
Dasatinib—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000898	0.00425	CcSEcCtD
Dasatinib—Asthma—Esomeprazole—Barrett's esophagus	0.000892	0.00422	CcSEcCtD
Dasatinib—Dysphagia—Esomeprazole—Barrett's esophagus	0.000892	0.00422	CcSEcCtD
Dasatinib—Asthma—Omeprazole—Barrett's esophagus	0.000892	0.00422	CcSEcCtD
Dasatinib—Dysphagia—Omeprazole—Barrett's esophagus	0.000892	0.00422	CcSEcCtD
Dasatinib—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000878	0.00415	CcSEcCtD
Dasatinib—Bronchospasm—Omeprazole—Barrett's esophagus	0.000878	0.00415	CcSEcCtD
Dasatinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.000875	0.00414	CcSEcCtD
Dasatinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000875	0.00414	CcSEcCtD
Dasatinib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000869	0.00411	CcSEcCtD
Dasatinib—Angina pectoris—Omeprazole—Barrett's esophagus	0.000869	0.00411	CcSEcCtD
Dasatinib—ABL1—digestive system—Barrett's esophagus	0.00086	0.00852	CbGeAlD
Dasatinib—Pancytopenia—Omeprazole—Barrett's esophagus	0.000847	0.00401	CcSEcCtD
Dasatinib—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000847	0.00401	CcSEcCtD
Dasatinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.000834	0.00394	CcSEcCtD
Dasatinib—Neutropenia—Omeprazole—Barrett's esophagus	0.000834	0.00394	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000829	0.00392	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000829	0.00392	CcSEcCtD
Dasatinib—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000824	0.0039	CcSEcCtD
Dasatinib—Pollakiuria—Omeprazole—Barrett's esophagus	0.000824	0.0039	CcSEcCtD
Dasatinib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000815	0.00385	CcSEcCtD
Dasatinib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000815	0.00385	CcSEcCtD
Dasatinib—Weight increased—Esomeprazole—Barrett's esophagus	0.000812	0.00384	CcSEcCtD
Dasatinib—Weight increased—Omeprazole—Barrett's esophagus	0.000812	0.00384	CcSEcCtD
Dasatinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.000807	0.00382	CcSEcCtD
Dasatinib—Weight decreased—Omeprazole—Barrett's esophagus	0.000807	0.00382	CcSEcCtD
Dasatinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000796	0.00376	CcSEcCtD
Dasatinib—Infestation—Omeprazole—Barrett's esophagus	0.000796	0.00376	CcSEcCtD
Dasatinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000796	0.00376	CcSEcCtD
Dasatinib—Infestation—Esomeprazole—Barrett's esophagus	0.000796	0.00376	CcSEcCtD
Dasatinib—Renal failure—Omeprazole—Barrett's esophagus	0.000782	0.0037	CcSEcCtD
Dasatinib—Renal failure—Esomeprazole—Barrett's esophagus	0.000782	0.0037	CcSEcCtD
Dasatinib—Stomatitis—Omeprazole—Barrett's esophagus	0.000776	0.00367	CcSEcCtD
Dasatinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000776	0.00367	CcSEcCtD
Dasatinib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000773	0.00366	CcSEcCtD
Dasatinib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000773	0.00366	CcSEcCtD
Dasatinib—Haematuria—Omeprazole—Barrett's esophagus	0.000759	0.00359	CcSEcCtD
Dasatinib—Haematuria—Esomeprazole—Barrett's esophagus	0.000759	0.00359	CcSEcCtD
Dasatinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000753	0.00356	CcSEcCtD
Dasatinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000753	0.00356	CcSEcCtD
Dasatinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000751	0.00355	CcSEcCtD
Dasatinib—Epistaxis—Omeprazole—Barrett's esophagus	0.000751	0.00355	CcSEcCtD
Dasatinib—CYP1B1—digestive system—Barrett's esophagus	0.000728	0.00721	CbGeAlD
Dasatinib—Hepatitis—Omeprazole—Barrett's esophagus	0.000714	0.00338	CcSEcCtD
Dasatinib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000714	0.00338	CcSEcCtD
Dasatinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000705	0.00333	CcSEcCtD
Dasatinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000705	0.00333	CcSEcCtD
Dasatinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000704	0.00333	CcSEcCtD
Dasatinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000704	0.00333	CcSEcCtD
Dasatinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000702	0.00332	CcSEcCtD
Dasatinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000702	0.00332	CcSEcCtD
Dasatinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.0007	0.00331	CcSEcCtD
Dasatinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.0007	0.00331	CcSEcCtD
Dasatinib—Visual impairment—Omeprazole—Barrett's esophagus	0.000688	0.00325	CcSEcCtD
Dasatinib—Visual impairment—Esomeprazole—Barrett's esophagus	0.000688	0.00325	CcSEcCtD
Dasatinib—CYP1A1—epithelium—Barrett's esophagus	0.000676	0.0067	CbGeAlD
Dasatinib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000675	0.00319	CcSEcCtD
Dasatinib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000675	0.00319	CcSEcCtD
Dasatinib—Eye disorder—Omeprazole—Barrett's esophagus	0.000668	0.00316	CcSEcCtD
Dasatinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.000668	0.00316	CcSEcCtD
Dasatinib—Tinnitus—Omeprazole—Barrett's esophagus	0.000666	0.00315	CcSEcCtD
Dasatinib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000666	0.00315	CcSEcCtD
Dasatinib—Flushing—Esomeprazole—Barrett's esophagus	0.000663	0.00313	CcSEcCtD
Dasatinib—Flushing—Omeprazole—Barrett's esophagus	0.000663	0.00313	CcSEcCtD
Dasatinib—Immune system disorder—Omeprazole—Barrett's esophagus	0.000645	0.00305	CcSEcCtD
Dasatinib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000645	0.00305	CcSEcCtD
Dasatinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000644	0.00304	CcSEcCtD
Dasatinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000644	0.00304	CcSEcCtD
Dasatinib—Chills—Esomeprazole—Barrett's esophagus	0.000641	0.00303	CcSEcCtD
Dasatinib—Chills—Omeprazole—Barrett's esophagus	0.000641	0.00303	CcSEcCtD
Dasatinib—Alopecia—Omeprazole—Barrett's esophagus	0.000631	0.00298	CcSEcCtD
Dasatinib—Alopecia—Esomeprazole—Barrett's esophagus	0.000631	0.00298	CcSEcCtD
Dasatinib—Mental disorder—Omeprazole—Barrett's esophagus	0.000626	0.00296	CcSEcCtD
Dasatinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000626	0.00296	CcSEcCtD
Dasatinib—Malnutrition—Omeprazole—Barrett's esophagus	0.000622	0.00294	CcSEcCtD
Dasatinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000622	0.00294	CcSEcCtD
Dasatinib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000609	0.00288	CcSEcCtD
Dasatinib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000609	0.00288	CcSEcCtD
Dasatinib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000598	0.00283	CcSEcCtD
Dasatinib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000598	0.00283	CcSEcCtD
Dasatinib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000586	0.00277	CcSEcCtD
Dasatinib—Vision blurred—Omeprazole—Barrett's esophagus	0.000586	0.00277	CcSEcCtD
Dasatinib—Tremor—Omeprazole—Barrett's esophagus	0.000583	0.00275	CcSEcCtD
Dasatinib—Tremor—Esomeprazole—Barrett's esophagus	0.000583	0.00275	CcSEcCtD
Dasatinib—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000577	0.00273	CcSEcCtD
Dasatinib—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000577	0.00273	CcSEcCtD
Dasatinib—Anaemia—Esomeprazole—Barrett's esophagus	0.000575	0.00272	CcSEcCtD
Dasatinib—Anaemia—Omeprazole—Barrett's esophagus	0.000575	0.00272	CcSEcCtD
Dasatinib—Malaise—Omeprazole—Barrett's esophagus	0.000561	0.00265	CcSEcCtD
Dasatinib—Malaise—Esomeprazole—Barrett's esophagus	0.000561	0.00265	CcSEcCtD
Dasatinib—Vertigo—Esomeprazole—Barrett's esophagus	0.000559	0.00264	CcSEcCtD
Dasatinib—Vertigo—Omeprazole—Barrett's esophagus	0.000559	0.00264	CcSEcCtD
Dasatinib—Palpitations—Omeprazole—Barrett's esophagus	0.000549	0.0026	CcSEcCtD
Dasatinib—Palpitations—Esomeprazole—Barrett's esophagus	0.000549	0.0026	CcSEcCtD
Dasatinib—Cough—Esomeprazole—Barrett's esophagus	0.000543	0.00256	CcSEcCtD
Dasatinib—Cough—Omeprazole—Barrett's esophagus	0.000543	0.00256	CcSEcCtD
Dasatinib—Hypertension—Omeprazole—Barrett's esophagus	0.000537	0.00254	CcSEcCtD
Dasatinib—Hypertension—Esomeprazole—Barrett's esophagus	0.000537	0.00254	CcSEcCtD
Dasatinib—Myalgia—Esomeprazole—Barrett's esophagus	0.000529	0.0025	CcSEcCtD
Dasatinib—Myalgia—Omeprazole—Barrett's esophagus	0.000529	0.0025	CcSEcCtD
Dasatinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000529	0.0025	CcSEcCtD
Dasatinib—Chest pain—Esomeprazole—Barrett's esophagus	0.000529	0.0025	CcSEcCtD
Dasatinib—Arthralgia—Omeprazole—Barrett's esophagus	0.000529	0.0025	CcSEcCtD
Dasatinib—Chest pain—Omeprazole—Barrett's esophagus	0.000529	0.0025	CcSEcCtD
Dasatinib—Anxiety—Esomeprazole—Barrett's esophagus	0.000528	0.00249	CcSEcCtD
Dasatinib—Anxiety—Omeprazole—Barrett's esophagus	0.000528	0.00249	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000526	0.00248	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000526	0.00248	CcSEcCtD
Dasatinib—Discomfort—Esomeprazole—Barrett's esophagus	0.000523	0.00247	CcSEcCtD
Dasatinib—Discomfort—Omeprazole—Barrett's esophagus	0.000523	0.00247	CcSEcCtD
Dasatinib—CYP1A2—digestive system—Barrett's esophagus	0.000522	0.00517	CbGeAlD
Dasatinib—CYP1A1—digestive system—Barrett's esophagus	0.000515	0.0051	CbGeAlD
Dasatinib—Confusional state—Esomeprazole—Barrett's esophagus	0.000512	0.00242	CcSEcCtD
Dasatinib—Confusional state—Omeprazole—Barrett's esophagus	0.000512	0.00242	CcSEcCtD
Dasatinib—Infection—Omeprazole—Barrett's esophagus	0.000504	0.00238	CcSEcCtD
Dasatinib—Infection—Esomeprazole—Barrett's esophagus	0.000504	0.00238	CcSEcCtD
Dasatinib—CYP3A5—digestive system—Barrett's esophagus	0.000503	0.00499	CbGeAlD
Dasatinib—Shock—Esomeprazole—Barrett's esophagus	0.000499	0.00236	CcSEcCtD
Dasatinib—Shock—Omeprazole—Barrett's esophagus	0.000499	0.00236	CcSEcCtD
Dasatinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000498	0.00235	CcSEcCtD
Dasatinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000498	0.00235	CcSEcCtD
Dasatinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000497	0.00235	CcSEcCtD
Dasatinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000497	0.00235	CcSEcCtD
Dasatinib—Tachycardia—Omeprazole—Barrett's esophagus	0.000495	0.00234	CcSEcCtD
Dasatinib—Tachycardia—Esomeprazole—Barrett's esophagus	0.000495	0.00234	CcSEcCtD
Dasatinib—Skin disorder—Omeprazole—Barrett's esophagus	0.000493	0.00233	CcSEcCtD
Dasatinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000493	0.00233	CcSEcCtD
Dasatinib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000491	0.00232	CcSEcCtD
Dasatinib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000491	0.00232	CcSEcCtD
Dasatinib—Anorexia—Esomeprazole—Barrett's esophagus	0.000484	0.00229	CcSEcCtD
Dasatinib—Anorexia—Omeprazole—Barrett's esophagus	0.000484	0.00229	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000462	0.00219	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000462	0.00219	CcSEcCtD
Dasatinib—Insomnia—Omeprazole—Barrett's esophagus	0.000459	0.00217	CcSEcCtD
Dasatinib—Insomnia—Esomeprazole—Barrett's esophagus	0.000459	0.00217	CcSEcCtD
Dasatinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000452	0.00214	CcSEcCtD
Dasatinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000452	0.00214	CcSEcCtD
Dasatinib—Somnolence—Omeprazole—Barrett's esophagus	0.000451	0.00213	CcSEcCtD
Dasatinib—Somnolence—Esomeprazole—Barrett's esophagus	0.000451	0.00213	CcSEcCtD
Dasatinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000447	0.00211	CcSEcCtD
Dasatinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000447	0.00211	CcSEcCtD
Dasatinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000441	0.00209	CcSEcCtD
Dasatinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000441	0.00209	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000438	0.00207	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000438	0.00207	CcSEcCtD
Dasatinib—Fatigue—Omeprazole—Barrett's esophagus	0.000438	0.00207	CcSEcCtD
Dasatinib—Fatigue—Esomeprazole—Barrett's esophagus	0.000438	0.00207	CcSEcCtD
Dasatinib—Pain—Omeprazole—Barrett's esophagus	0.000434	0.00205	CcSEcCtD
Dasatinib—Pain—Esomeprazole—Barrett's esophagus	0.000434	0.00205	CcSEcCtD
Dasatinib—Constipation—Omeprazole—Barrett's esophagus	0.000434	0.00205	CcSEcCtD
Dasatinib—Constipation—Esomeprazole—Barrett's esophagus	0.000434	0.00205	CcSEcCtD
Dasatinib—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000418	0.00198	CcSEcCtD
Dasatinib—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000418	0.00198	CcSEcCtD
Dasatinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000415	0.00196	CcSEcCtD
Dasatinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000415	0.00196	CcSEcCtD
Dasatinib—Urticaria—Omeprazole—Barrett's esophagus	0.000403	0.00191	CcSEcCtD
Dasatinib—Urticaria—Esomeprazole—Barrett's esophagus	0.000403	0.00191	CcSEcCtD
Dasatinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000401	0.0019	CcSEcCtD
Dasatinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000401	0.0019	CcSEcCtD
Dasatinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000401	0.0019	CcSEcCtD
Dasatinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000401	0.0019	CcSEcCtD
Dasatinib—CYP3A4—digestive system—Barrett's esophagus	0.000378	0.00374	CbGeAlD
Dasatinib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000374	0.00177	CcSEcCtD
Dasatinib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000374	0.00177	CcSEcCtD
Dasatinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000364	0.00172	CcSEcCtD
Dasatinib—Asthenia—Omeprazole—Barrett's esophagus	0.000364	0.00172	CcSEcCtD
Dasatinib—Pruritus—Omeprazole—Barrett's esophagus	0.000359	0.0017	CcSEcCtD
Dasatinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000359	0.0017	CcSEcCtD
Dasatinib—ABCB1—epithelium—Barrett's esophagus	0.000351	0.00348	CbGeAlD
Dasatinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000347	0.00164	CcSEcCtD
Dasatinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000347	0.00164	CcSEcCtD
Dasatinib—Dizziness—Omeprazole—Barrett's esophagus	0.000336	0.00159	CcSEcCtD
Dasatinib—Dizziness—Esomeprazole—Barrett's esophagus	0.000336	0.00159	CcSEcCtD
Dasatinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000323	0.00153	CcSEcCtD
Dasatinib—Vomiting—Omeprazole—Barrett's esophagus	0.000323	0.00153	CcSEcCtD
Dasatinib—Rash—Esomeprazole—Barrett's esophagus	0.00032	0.00151	CcSEcCtD
Dasatinib—Rash—Omeprazole—Barrett's esophagus	0.00032	0.00151	CcSEcCtD
Dasatinib—Dermatitis—Omeprazole—Barrett's esophagus	0.00032	0.00151	CcSEcCtD
Dasatinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.00032	0.00151	CcSEcCtD
Dasatinib—Headache—Omeprazole—Barrett's esophagus	0.000318	0.0015	CcSEcCtD
Dasatinib—Headache—Esomeprazole—Barrett's esophagus	0.000318	0.0015	CcSEcCtD
Dasatinib—Nausea—Omeprazole—Barrett's esophagus	0.000301	0.00142	CcSEcCtD
Dasatinib—Nausea—Esomeprazole—Barrett's esophagus	0.000301	0.00142	CcSEcCtD
Dasatinib—ABCB1—digestive system—Barrett's esophagus	0.000267	0.00265	CbGeAlD
Dasatinib—KIT—Signaling Pathways—GAST—Barrett's esophagus	3.78e-05	0.000267	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—SST—Barrett's esophagus	3.78e-05	0.000266	CbGpPWpGaD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.77e-05	0.000266	CbGpPWpGaD
Dasatinib—PDGFRB—MAPK Signaling Pathway—TP53—Barrett's esophagus	3.77e-05	0.000266	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—SST—Barrett's esophagus	3.75e-05	0.000265	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—HGF—Barrett's esophagus	3.73e-05	0.000263	CbGpPWpGaD
Dasatinib—CSK—Hemostasis—TP53—Barrett's esophagus	3.66e-05	0.000258	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HGF—Barrett's esophagus	3.64e-05	0.000257	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—RELA—Barrett's esophagus	3.63e-05	0.000256	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—RELA—Barrett's esophagus	3.61e-05	0.000254	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—GAST—Barrett's esophagus	3.58e-05	0.000252	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—SLC9A1—Barrett's esophagus	3.53e-05	0.000249	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CYP26A1—Barrett's esophagus	3.51e-05	0.000247	CbGpPWpGaD
Dasatinib—MAPK14—MAPK Signaling Pathway—TP53—Barrett's esophagus	3.5e-05	0.000247	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—RELA—Barrett's esophagus	3.49e-05	0.000246	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	3.47e-05	0.000245	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—SST—Barrett's esophagus	3.43e-05	0.000242	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—SST—Barrett's esophagus	3.43e-05	0.000242	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—RELA—Barrett's esophagus	3.41e-05	0.000241	CbGpPWpGaD
Dasatinib—FYN—Disease—SLC9A1—Barrett's esophagus	3.4e-05	0.00024	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—PPARG—Barrett's esophagus	3.32e-05	0.000234	CbGpPWpGaD
Dasatinib—CSK—Immune System—RELA—Barrett's esophagus	3.32e-05	0.000234	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.31e-05	0.000234	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	3.31e-05	0.000233	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—SST—Barrett's esophagus	3.31e-05	0.000233	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—HGF—Barrett's esophagus	3.3e-05	0.000233	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—PPARG—Barrett's esophagus	3.27e-05	0.000231	CbGpPWpGaD
Dasatinib—SRC—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	3.25e-05	0.000229	CbGpPWpGaD
Dasatinib—JAK2—Disease—SLC9A1—Barrett's esophagus	3.24e-05	0.000228	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—GAST—Barrett's esophagus	3.23e-05	0.000227	CbGpPWpGaD
Dasatinib—MAPK14—Cellular Senescence—TP53—Barrett's esophagus	3.22e-05	0.000227	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—RELA—Barrett's esophagus	3.21e-05	0.000227	CbGpPWpGaD
Dasatinib—YES1—Immune System—HGF—Barrett's esophagus	3.2e-05	0.000226	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	3.19e-05	0.000225	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—RELA—Barrett's esophagus	3.19e-05	0.000225	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	3.16e-05	0.000223	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—GAST—Barrett's esophagus	3.16e-05	0.000223	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.15e-05	0.000222	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—PPARG—Barrett's esophagus	3.15e-05	0.000222	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—PPARG—Barrett's esophagus	3.11e-05	0.000219	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—GAST—Barrett's esophagus	3.11e-05	0.000219	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—RELA—Barrett's esophagus	3.06e-05	0.000216	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—RELA—Barrett's esophagus	3.04e-05	0.000215	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—RELA—Barrett's esophagus	3.02e-05	0.000213	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.02e-05	0.000213	CbGpPWpGaD
Dasatinib—HCK—Disease—APC—Barrett's esophagus	3.01e-05	0.000212	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—GAST—Barrett's esophagus	2.99e-05	0.000211	CbGpPWpGaD
Dasatinib—CSK—Disease—PTGS2—Barrett's esophagus	2.98e-05	0.00021	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—GAST—Barrett's esophagus	2.96e-05	0.000208	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—SST—Barrett's esophagus	2.9e-05	0.000205	CbGpPWpGaD
Dasatinib—STAT5B—Disease—PTGS2—Barrett's esophagus	2.88e-05	0.000203	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—CXCL8—Barrett's esophagus	2.87e-05	0.000202	CbGpPWpGaD
Dasatinib—KIT—Immune System—HGF—Barrett's esophagus	2.86e-05	0.000201	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—RELA—Barrett's esophagus	2.85e-05	0.000201	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGES—Barrett's esophagus	2.85e-05	0.000201	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—RELA—Barrett's esophagus	2.85e-05	0.000201	CbGpPWpGaD
Dasatinib—LCK—Disease—SLC9A1—Barrett's esophagus	2.83e-05	0.0002	CbGpPWpGaD
Dasatinib—BTK—Immune System—RELA—Barrett's esophagus	2.78e-05	0.000196	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—APC—Barrett's esophagus	2.75e-05	0.000194	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—RELA—Barrett's esophagus	2.73e-05	0.000193	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HGF—Barrett's esophagus	2.7e-05	0.000191	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—RELA—Barrett's esophagus	2.69e-05	0.00019	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—RELA—Barrett's esophagus	2.69e-05	0.00019	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	2.68e-05	0.000189	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—APC—Barrett's esophagus	2.66e-05	0.000187	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	2.65e-05	0.000187	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—RELA—Barrett's esophagus	2.65e-05	0.000187	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—SST—Barrett's esophagus	2.59e-05	0.000183	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.59e-05	0.000183	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—GAST—Barrett's esophagus	2.59e-05	0.000183	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—RELA—Barrett's esophagus	2.59e-05	0.000182	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—PPARG—Barrett's esophagus	2.57e-05	0.000181	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—RELA—Barrett's esophagus	2.55e-05	0.00018	CbGpPWpGaD
Dasatinib—HCK—Immune System—RELA—Barrett's esophagus	2.55e-05	0.00018	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—TP53—Barrett's esophagus	2.54e-05	0.000179	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—SLC9A1—Barrett's esophagus	2.53e-05	0.000178	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—RELA—Barrett's esophagus	2.52e-05	0.000178	CbGpPWpGaD
Dasatinib—SRC—Disease—SLC9A1—Barrett's esophagus	2.51e-05	0.000177	CbGpPWpGaD
Dasatinib—ERBB3—Disease—APC—Barrett's esophagus	2.5e-05	0.000176	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—SST—Barrett's esophagus	2.45e-05	0.000173	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HGF—Barrett's esophagus	2.44e-05	0.000172	CbGpPWpGaD
Dasatinib—MAPK14—Cellular responses to stress—TP53—Barrett's esophagus	2.44e-05	0.000172	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—RELA—Barrett's esophagus	2.43e-05	0.000171	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.41e-05	0.00017	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—PPARG—Barrett's esophagus	2.41e-05	0.00017	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	2.4e-05	0.000169	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—RELA—Barrett's esophagus	2.4e-05	0.000169	CbGpPWpGaD
Dasatinib—LYN—Immune System—HGF—Barrett's esophagus	2.39e-05	0.000168	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—RELA—Barrett's esophagus	2.38e-05	0.000168	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HGF—Barrett's esophagus	2.37e-05	0.000167	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	2.37e-05	0.000167	CbGpPWpGaD
Dasatinib—FYN—Immune System—HGF—Barrett's esophagus	2.35e-05	0.000166	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—RELA—Barrett's esophagus	2.34e-05	0.000165	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—RELA—Barrett's esophagus	2.33e-05	0.000164	CbGpPWpGaD
Dasatinib—BLK—Immune System—RELA—Barrett's esophagus	2.31e-05	0.000163	CbGpPWpGaD
Dasatinib—FGR—Immune System—RELA—Barrett's esophagus	2.3e-05	0.000162	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	2.3e-05	0.000162	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—GAST—Barrett's esophagus	2.29e-05	0.000162	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	2.29e-05	0.000161	CbGpPWpGaD
Dasatinib—HCK—Disease—PTGS2—Barrett's esophagus	2.28e-05	0.000161	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—RELA—Barrett's esophagus	2.28e-05	0.000161	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	2.28e-05	0.00016	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HGF—Barrett's esophagus	2.26e-05	0.000159	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—RELA—Barrett's esophagus	2.25e-05	0.000159	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—RELA—Barrett's esophagus	2.25e-05	0.000158	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HGF—Barrett's esophagus	2.23e-05	0.000157	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—RELA—Barrett's esophagus	2.22e-05	0.000157	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SST—Barrett's esophagus	2.21e-05	0.000156	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SST—Barrett's esophagus	2.16e-05	0.000153	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	2.16e-05	0.000152	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—RELA—Barrett's esophagus	2.14e-05	0.000151	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SST—Barrett's esophagus	2.13e-05	0.00015	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—RELA—Barrett's esophagus	2.11e-05	0.000149	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—RELA—Barrett's esophagus	2.08e-05	0.000146	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SST—Barrett's esophagus	2.05e-05	0.000145	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—TP53—Barrett's esophagus	2.05e-05	0.000144	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.04e-05	0.000144	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SST—Barrett's esophagus	2.03e-05	0.000143	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—PTGS2—Barrett's esophagus	2.02e-05	0.000143	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—CXCL8—Barrett's esophagus	2.02e-05	0.000143	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—APC—Barrett's esophagus	1.98e-05	0.00014	CbGpPWpGaD
Dasatinib—KIT—Disease—APC—Barrett's esophagus	1.96e-05	0.000138	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—CXCL8—Barrett's esophagus	1.96e-05	0.000138	CbGpPWpGaD
Dasatinib—LCK—Immune System—HGF—Barrett's esophagus	1.96e-05	0.000138	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—RELA—Barrett's esophagus	1.95e-05	0.000138	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—RELA—Barrett's esophagus	1.95e-05	0.000137	CbGpPWpGaD
Dasatinib—ERBB3—Disease—PTGS2—Barrett's esophagus	1.9e-05	0.000134	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	1.87e-05	0.000132	CbGpPWpGaD
Dasatinib—YES1—Immune System—RELA—Barrett's esophagus	1.86e-05	0.000131	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—APC—Barrett's esophagus	1.85e-05	0.000131	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	1.82e-05	0.000128	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—APC—Barrett's esophagus	1.82e-05	0.000128	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SST—Barrett's esophagus	1.77e-05	0.000125	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—TP53—Barrett's esophagus	1.76e-05	0.000124	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—APC—Barrett's esophagus	1.75e-05	0.000123	CbGpPWpGaD
Dasatinib—SRC—Immune System—HGF—Barrett's esophagus	1.73e-05	0.000122	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	1.72e-05	0.000122	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—RELA—Barrett's esophagus	1.72e-05	0.000122	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—APC—Barrett's esophagus	1.67e-05	0.000118	CbGpPWpGaD
Dasatinib—KIT—Immune System—RELA—Barrett's esophagus	1.66e-05	0.000117	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—RELA—Barrett's esophagus	1.66e-05	0.000117	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	1.65e-05	0.000116	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—PPARG—Barrett's esophagus	1.61e-05	0.000114	CbGpPWpGaD
Dasatinib—FYN—Disease—APC—Barrett's esophagus	1.61e-05	0.000114	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.6e-05	0.000113	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SST—Barrett's esophagus	1.57e-05	0.000111	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—RELA—Barrett's esophagus	1.57e-05	0.000111	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	1.56e-05	0.00011	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—RELA—Barrett's esophagus	1.55e-05	0.000109	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—APC—Barrett's esophagus	1.54e-05	0.000108	CbGpPWpGaD
Dasatinib—JAK2—Disease—APC—Barrett's esophagus	1.53e-05	0.000108	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—TP53—Barrett's esophagus	1.53e-05	0.000108	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—TP53—Barrett's esophagus	1.52e-05	0.000107	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—TP53—Barrett's esophagus	1.5e-05	0.000106	CbGpPWpGaD
Dasatinib—KIT—Disease—PTGS2—Barrett's esophagus	1.49e-05	0.000105	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.47e-05	0.000104	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CXCL8—Barrett's esophagus	1.46e-05	0.000103	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—TP53—Barrett's esophagus	1.45e-05	0.000102	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.43e-05	0.000101	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—TP53—Barrett's esophagus	1.43e-05	0.000101	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—RELA—Barrett's esophagus	1.42e-05	0.0001	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—RELA—Barrett's esophagus	1.41e-05	9.97e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—PTGS2—Barrett's esophagus	1.41e-05	9.93e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.4e-05	9.89e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—RELA—Barrett's esophagus	1.38e-05	9.76e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—RELA—Barrett's esophagus	1.38e-05	9.71e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.38e-05	9.71e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—APC—Barrett's esophagus	1.37e-05	9.67e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—RELA—Barrett's esophagus	1.37e-05	9.64e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—RELA—Barrett's esophagus	1.36e-05	9.61e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—APC—Barrett's esophagus	1.34e-05	9.45e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CXCL8—Barrett's esophagus	1.34e-05	9.43e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CXCL8—Barrett's esophagus	1.34e-05	9.42e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—RELA—Barrett's esophagus	1.31e-05	9.25e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—APC—Barrett's esophagus	1.3e-05	9.16e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—RELA—Barrett's esophagus	1.3e-05	9.13e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CXCL8—Barrett's esophagus	1.29e-05	9.09e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—PTGS2—Barrett's esophagus	1.27e-05	8.94e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.25e-05	8.85e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TP53—Barrett's esophagus	1.25e-05	8.82e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.24e-05	8.77e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TP53—Barrett's esophagus	1.24e-05	8.75e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—PTGS2—Barrett's esophagus	1.22e-05	8.62e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TP53—Barrett's esophagus	1.2e-05	8.47e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—RELA—Barrett's esophagus	1.2e-05	8.46e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—APC—Barrett's esophagus	1.19e-05	8.37e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—APC—Barrett's esophagus	1.17e-05	8.25e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—PTGS2—Barrett's esophagus	1.16e-05	8.19e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PPARG—Barrett's esophagus	1.15e-05	8.14e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—APC—Barrett's esophagus	1.15e-05	8.08e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—RELA—Barrett's esophagus	1.13e-05	8e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CXCL8—Barrett's esophagus	1.13e-05	7.98e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—APC—Barrett's esophagus	1.13e-05	7.95e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TP53—Barrett's esophagus	1.11e-05	7.81e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—APC—Barrett's esophagus	1.09e-05	7.66e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RELA—Barrett's esophagus	1.07e-05	7.56e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APC—Barrett's esophagus	1.07e-05	7.56e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.06e-05	7.49e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.05e-05	7.4e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—Barrett's esophagus	1.02e-05	7.18e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.02e-05	7.17e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RELA—Barrett's esophagus	1.01e-05	7.15e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CXCL8—Barrett's esophagus	1.01e-05	7.12e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—RELA—Barrett's esophagus	1e-05	7.08e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	9.92e-06	7e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CXCL8—Barrett's esophagus	9.56e-06	6.74e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APC—Barrett's esophagus	9.39e-06	6.62e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RELA—Barrett's esophagus	9.14e-06	6.45e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—Barrett's esophagus	9.08e-06	6.4e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—Barrett's esophagus	9.01e-06	6.35e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—Barrett's esophagus	8.97e-06	6.32e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RELA—Barrett's esophagus	8.95e-06	6.31e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RELA—Barrett's esophagus	8.81e-06	6.21e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL8—Barrett's esophagus	8.61e-06	6.07e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RELA—Barrett's esophagus	8.48e-06	5.98e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL8—Barrett's esophagus	8.43e-06	5.95e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RELA—Barrett's esophagus	8.37e-06	5.91e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APC—Barrett's esophagus	8.31e-06	5.86e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL8—Barrett's esophagus	8.3e-06	5.85e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	8.26e-06	5.82e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—Barrett's esophagus	8.2e-06	5.78e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8e-06	5.64e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—Barrett's esophagus	7.99e-06	5.64e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—Barrett's esophagus	7.91e-06	5.58e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—Barrett's esophagus	7.89e-06	5.57e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	7.66e-06	5.4e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	7.52e-06	5.3e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RELA—Barrett's esophagus	7.33e-06	5.17e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—Barrett's esophagus	7.1e-06	5.01e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—Barrett's esophagus	6.94e-06	4.89e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	6.91e-06	4.87e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RELA—Barrett's esophagus	6.49e-06	4.58e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—Barrett's esophagus	6.2e-06	4.37e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—Barrett's esophagus	6.12e-06	4.32e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	5.92e-06	4.17e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—Barrett's esophagus	5.87e-06	4.14e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	5.67e-06	4e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	5.59e-06	3.94e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—Barrett's esophagus	5.29e-06	3.73e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—Barrett's esophagus	5.17e-06	3.65e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—Barrett's esophagus	5.09e-06	3.59e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—Barrett's esophagus	4.91e-06	3.46e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—Barrett's esophagus	4.84e-06	3.42e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	4.53e-06	3.19e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	4.46e-06	3.15e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—Barrett's esophagus	4.24e-06	2.99e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—Barrett's esophagus	3.76e-06	2.65e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	3.56e-06	2.51e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	3.5e-06	2.47e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	2.75e-06	1.94e-05	CbGpPWpGaD
